Aim: To provide the current status of quality of life research in obesity, the usefulness of health-related quality of life (HRQL) as outcome measure in clinical studies: rationale, conceptual and measurement model, and interpretations. State-of-the-art: Standardised questionnaires, self-administe-red by patients, include key domains in everyday functioning and well being. Thecontent is bothobesity-related andgeneric, and the improvements are evaluated in relation to weight loss. Most importantly, HRQL measures can provide new and valid information of clinical value as demonstrated e.g. in the Swedish Obese Subjects intervention study over 10 years. Poor HRQL is permanently reversed if weight loss is substantial, i.e., compare well with the levels of the general population, more so for psychosocial functioning and mental well being than physical functioning. Obesity-specific scales are most responsive also to moderate andsmall magnitudes of weight loss. Clinicaltrials can be powered according to HRQL as primary or secondary outcome. It is newly introduced in pharmaceutical trials and in systematic literature reviews for evidence based medicine. Mission statement: HRQL is a useful concept in obesity research, the methods are available and the impact of weight loss is better understood if HRQL changes are added to the traditional clinical 
